Susquehanna International Group, LLP Pliant Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 46,638 shares of PLRX stock, worth $579,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,638

Previous 29,436 58.44%

Holding current value

$579,710

Previous $316,000 65.19%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $180,965 - $246,848	17,202 Added 58.44%	46,638 $522,000
Q2 2024 Aug 15, 2024	BUY	$10.58 - $15.61 $70,790 - $104,446	6,691 Added 29.42%	29,436 $316,000
Q1 2024 May 07, 2024	SELL	$14.14 - $19.59 $775,748 - $1.07 Million	-54,862 Reduced 70.69%	22,745 $338,000
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $859,677 - $1.28 Million	-66,901 Reduced 46.3%	77,607 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $1.25 Million - $1.73 Million	85,624 Added 145.41%	144,508 $2.51 Million
Q2 2023 Aug 11, 2023	SELL	$18.12 - $30.56 $9.77 Million - $16.5 Million	-538,987 Reduced 90.15%	58,884 $1.07 Million
Q1 2023 May 16, 2023	BUY	$18.73 - $36.26 $3.24 Million - $6.27 Million	172,975 Added 40.71%	597,871 $15.9 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $6.17 Million - $9.23 Million	362,799 Added 584.25%	424,896 $8.21 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $94,379 - $298,150	12,305 Added 24.71%	62,097 $1.3 Million
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $204,645 - $435,680	49,792 New	49,792 $399,000
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $204,012 - $410,352	-29,103 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $146,687 - $218,298	11,955 Added 69.72%	29,103 $393,000
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $167,914 - $295,277	10,189 Added 146.41%	17,148 $289,000
Q2 2021 Aug 11, 2021	SELL	$28.05 - $37.69 $522,823 - $702,503	-18,639 Reduced 72.81%	6,959 $203,000
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $270,798 - $444,300	11,044 Added 75.88%	25,598 $1.01 Million
Q4 2020 Feb 16, 2021	SELL	$19.89 - $32.99 $459,717 - $762,497	-23,113 Reduced 61.36%	14,554 $331,000
Q3 2020 Nov 16, 2020	BUY	$21.54 - $29.53 $811,347 - $1.11 Million	37,667 New	37,667 $853,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $605M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Pliant Therapeutics, Inc. Transaction History